SUSMED, Inc. Hits Day High with Strong 11.66% Intraday Surge

SUSMED, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock price, gaining 11.66% on March 10, 2026. The stock reached an intraday high of JPY 1,153.00, reflecting a strong performance relative to the Japan Nikkei 225, which rose by 2.88% on the same day. Over the past week, SUSMED has shown a robust increase of 9.53%, while its monthly performance stands at 12.43%. Impressively, the stock has surged by 90.55% over the past year, outpacing the Nikkei 225's 46.51% gain. Year-to-date, SUSMED has delivered a solid return of 36.14%, significantly higher than the Nikkei's 7.77%. Despite these positive short-term trends, the company faces challenges, including a low return on equity of 0.04%, indicating limited profitability relative to shareholder funds. Additionally, SUSMED has reported negative EBITDA, suggesting ongoing financial risks. As the company navigates these dynamics, its recent stock performance highlights notable activity in the market.